In patients with inflammatory bowel disease, neither biologics nor small molecule targeted therapies increase the risk for major adverse cardiac…
Browsing: Hot headlines in GI
The article from Cureus focuses on the advancements in early cancer detection, exploring the roles of biomarkers, circulating DNA (ctDNA),…
The Yahoo Finance article discusses predictions for how artificial intelligence (AI) will impact various aspects of healthcare in 2024. The…
Medtronic has expanded its partnership with Cosmo Intelligent Medical Devices to further develop and capitalize on the GI Genius intelligent…
The Healio article discusses the efforts of the American Society for Gastrointestinal Endoscopy’s (ASGE) diversity, equity, and inclusion (DEI) subcommittee…
Ayble Health, a digital health platform for patients with chronic gastrointestinal (GI) conditions, has announced a partnership with Commure Engage,…
A study from the Perelman School of Medicine at the University of Pennsylvania found that liver cancer screening rates among…
Patients with cirrhosis are especially susceptible to liver cancer, but mailing screening orders directly to patients helped nudge them toward…
The Becker’s ASC Review article highlights the top five gastroenterology stories of 2023, capturing significant events and developments in the…
The Fierce Healthcare article discusses the outlook for 2024 regarding the use of GLP-1 medications, particularly in the context of…